首页> Anticancer research> Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study.

Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study.

导出原文传递

翻译打印收藏纠错

第一作者： Akihiro,Tamiya

第一单位： National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan atamiya@kch.hosp.go.jp.

作者： Akihiro,Tamiya ^[1] ; Motohiro,Tamiya ^[2] ; Takashi,Nishihara ^[2] ; Takayuki,Shiroyama ^[2] ; Keiko,Nakao ^[3] ; Taisuke,Tsuji ^[3] ; Naoko,Takeuchi ^[3] ; Shun-Ichi,Isa ^[3] ; Naoki,Omachi ^[3] ; Norio,Okamoto ^[2] ; Hidekazu,Suzuki ^[2] ; Kyoichi,Okishio ^[3] ; Ayano,Iwazaki ^[4] ; Kimie,Imai ^[4] ; Tomonori,Hirashima ^[2] ; Shinji,Atagi ^[3]

作者单位： National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan atamiya@kch.hosp.go.jp. ^[1] Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino, Japan. ^[2] National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan. ^[3] Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan. ^[4]

关键词 Afatinib cerebrospinal fluid penetration rate epidermal growth factor receptor leptomeningeal carcinomatosis